S. Meier

发表

Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib.

R. Larson, H. Kantarjian, G. Rosti, 2014, Blood.

The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma

G. Hommel, H. Gabbert, W. Müller, 1995, Cancer.

Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer

G. Hommel, K. Heider, H. Gabbert, 1997, The Journal of pathology.

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study

D. Conen, K. Blennow, C. Granziera, 2022, The Lancet Neurology.

Prognostic value of E‐cadherin expression in 413 gastric carcinomas

W. Birchmeier, R. Moll, H. Gabbert, 1996, International journal of cancer.

Tumor‐cell dissociation at the invasion front: A new prognostic parameter in gastric cancer patients

H E Gabbert, G. Hommel, C. Gerharz, 1992, International journal of cancer.

Incidence and prognostic significance of vascular invasion in 529 gastric‐cancer patients

G. Hommel, C. Gerharz, H. Gabbert, 1991, International journal of cancer.

Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma.

G. Hommel, H. Gabbert, A. Schneiders, 1996, British Journal of Cancer.

myeloid leukemia in chronic phase treated with frontline nilotinib or Early molecular response predicts outcomes in patients with chronic

R. Larson, H. Kantarjian, R. Ribeiro, 2014 .